Zun-Yi Wang Selected Research

Cyclophosphamide (Cytoxan)

4/2015	Attenuation of cystitis and pain sensation in mice lacking fatty acid amide hydrolase.
10/2009	Role of mast cells and protease-activated receptor-2 in cyclooxygenase-2 expression in urothelial cells.
9/2008	Lack of TRPV1 inhibits cystitis-induced increased mechanical sensitivity in mice.
6/2007	Acute acrolein-induced cystitis in mice.
1/2006	Nerve growth factor mediates peripheral mechanical hypersensitivity that accompanies experimental cystitis in mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Zun-Yi Wang Research Topics

Disease

12	Cystitis 04/2015 - 01/2006
11	Inflammation (Inflammations) 04/2015 - 01/2006
6	Hyperalgesia 01/2015 - 07/2008
5	Pain (Aches) 01/2018 - 10/2011
4	Neoplasms (Cancer) 01/2020 - 12/2004
2	Breast Neoplasms (Breast Cancer) 01/2020 - 01/2020
2	Visceral Pain 01/2018 - 09/2008
2	Edema (Dropsy) 01/2015 - 04/2014
1	Hypoxia (Hypoxemia) 01/2020
1	Carcinogenesis 01/2020
1	Colorectal Neoplasms (Colorectal Cancer) 12/2019
1	Nociceptive Pain 01/2018
1	Urinary Bladder Diseases (Bladder Diseases) 04/2014
1	Interstitial Cystitis (Interstitial Cystitis, Chronic) 06/2011
1	Urologic Diseases (Urinary Tract Disease) 06/2011
1	Urinary Bladder Neoplasms (Bladder Cancer) 03/2008
1	Transitional Cell Carcinoma 03/2008
1	Hypersensitivity (Allergy) 01/2006
1	Corneal Neovascularization 12/2004
1	Necrosis 12/2004
1	Ganglion Cysts (Ganglion) 01/2002

Drug/Important Bio-Agent (IBA)

8	Acrolein (Aqualin)IBA 01/2015 - 06/2007
6	Nerve Growth Factor (NGF)IBA 03/2015 - 01/2006
5	Cyclophosphamide (Cytoxan)FDA LinkGeneric 04/2015 - 01/2006
3	Proteins (Proteins, Gene)FDA Link 10/2009 - 12/2004
2	Messenger RNA (mRNA)IBA 01/2020 - 03/2008
2	EnzymesIBA 01/2018 - 10/2011
2	fatty-acid amide hydrolase (fatty acid amide hydrolase)IBA 04/2015 - 10/2011
2	CannabinoidsIBA 04/2015 - 09/2013
2	Cannabinoid Receptors (Cannabinoid Receptor)IBA 04/2014 - 05/2013
2	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 10/2009 - 09/2008
2	staurosporine aglycone (K252a)IBA 07/2008 - 01/2006
1	Phosphotransferases (Kinase)IBA 01/2020
1	Transcription Factors (Transcription Factor)IBA 01/2020
1	RNA (Ribonucleic Acid)IBA 01/2020
1	Trastuzumab (Herceptin)FDA Link 01/2020
1	Long Noncoding RNAIBA 01/2020
1	Untranslated RNA (Noncoding RNA)IBA 01/2020
1	Pharmaceutical PreparationsIBA 01/2020
1	Therapeutic UsesIBA 01/2020
1	Proliferating Cell Nuclear Antigen (PCNA)IBA 12/2019
1	fibrin fragment D (D-dimer)IBA 12/2019
1	AlbuminsIBA 12/2019
1	C-Reactive ProteinIBA 12/2019
1	EndocannabinoidsIBA 01/2018
1	Opioid Analgesics (Opioids)IBA 01/2018
1	arachidonyl-2-chloroethylamideIBA 01/2015
1	iodopravadoline (AM 630)IBA 04/2014
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 09/2013
1	cyclohexyl carbamic acid 3'-carbamoylbiphenyl-3-yl ester (URB597)IBA 10/2011
1	Fatty Acids (Saturated Fatty Acids)IBA 10/2011
1	anandamide (arachidonylethanolamide)IBA 10/2011
1	Interleukin-6 (Interleukin 6)IBA 06/2011
1	LipopolysaccharidesIBA 06/2011
1	Tryptases (Tryptase)IBA 10/2009
1	Peptide Hydrolases (Proteases)FDA Link 10/2009
1	Lidocaine (Xylocaine)FDA LinkGeneric 01/2009
1	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 09/2008
1	Indicators and Reagents (Reagents)IBA 09/2008
1	Bradykinin Receptors (Bradykinin Receptor)IBA 09/2008
1	Nerve Growth Factors (Neurotrophins)IBA 07/2008
1	PlasticsIBA 07/2008
1	Estrogen Receptor betaIBA 03/2008
1	Estrogens (Estrogen)FDA Link 03/2008
1	Cyclin EIBA 03/2008
1	Cyclin D1IBA 03/2008
1	Estrogen Receptor alphaIBA 03/2008
1	4-trifluoromethylsalicylic acid (HTB)IBA 03/2008
1	Toll-Like Receptor 4IBA 02/2008
1	Interleukin-12 (IL 12)IBA 12/2004
1	LigandsIBA 12/2004
1	InterleukinsIBA 12/2004
1	Integrin alphaVbeta3IBA 12/2004
1	Interleukin-12 Receptors (Interleukin 12 Receptor)IBA 12/2004
1	Peptides (Polypeptides)IBA 12/2004
1	5-HT3 Serotonin Receptors (5 HT3 Receptor)IBA 01/2002
1	Tyrosine 3-Monooxygenase (Tyrosine Hydroxylase)IBA 01/2002

Therapy/Procedure

8	Intravesical Administration 04/2014 - 06/2007
2	Drug Therapy (Chemotherapy) 01/2020 - 01/2020
1	Microspheres (Microsphere) 01/2020
1	Radiotherapy 01/2020
1	Therapeutics 01/2018
1	Analgesia 09/2013
1	Intraperitoneal Injections 01/2006